Report on industrial attachment with Glaxo Wellcome Manufacturing Pte Ltd by Teo, Edwin Zaiyi

“…The purpose of this report is first and foremost, to share about the work performed and the experiences gained during the Industrial Attachment period, from 13-Jan-14 to 31-May-14, with Glaxo Wellcome Manufacturing Pte Ltd (GSK), Planning & Logistics Department. …”
Get full text

Asthma leaflets for patients: what do asthma nurses use? by Jaffray, M, Osman, L, Mackenzie, J, Stearn, R

“…Assessment of NAC, Glaxo-Wellcome and Astra booklets revealed that they conformed to British Thoracic Society Guidelines for acute asthma. …”

Almost Common Value Auctions: The "Wallet Game" and its Applications to Takeover Battles and Airwaves Auctions. by Klemperer, P

“…We discuss applications to Airwaves Auctions and Takeover Battles including the Glaxo-Wellcome Merger.…”

A public-private partnership for malaria control: lessons from the Malarone Donation Programme by Oyediran A.B.O. Olukayode, Ddumba Edward M., Ochola Samuel A., Lucas Adetokunbo O., Koporc Kim, Dowdle Walter R.

“…In 1996, Glaxo Wellcome offered to donate up to a million treatment courses annually of Malarone, a new antimalarial, with a view to reducing the global burden of malaria. …”
Get full text

Evaluation of acute phase protein indexes in dogs with leishmaniasis at diagnosis, during and after short-term treatment by S. Martinez-Subiela, J.J. Ceron

“…Six dogs naturally infected by Leishmania infantum were treated with meglumine antimoniate (Glucantime, Merial, Lyon, France) 100 mg/kg/day sc, given concurrently for 20 days with allopurinol (Zyloric®, Glaxo Wellcome, Madrid, Spain) 30 mg/kg/day po and then, allopurinol alone for one month at the same dosage. …”
Get full text

Degradación de piridinedioles tóxicos derivados de la mimosina por bacterias ruminales: I. Aspectos microbiológicos by Marco Rincón, María Domínguez Bello, Milagros Lovera, Roberto Romero

Get full text

Can a selective adenosine A1-agonist protect against exercise-induced ischaemic left ventricular dysfunction? by Kelion, A, Webb, T, Gardner, M, Ormerod, O, Banning, A

“…We investigated whether warm-up can be reproduced by a selective adenosine A1-agonist, GR79236 (Glaxo-Wellcome). Methods. 25 patients with three vessel coronary disease and normal resting LV function entered a double-blind crossover study, receiving IV GR79236 10μg/kg or placebo on mornings one week apart. …”